Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 5/2017

30.03.2017 | General Gynecology

Physiotherapy and behavior therapy for the treatment of overactive bladder syndrome: a prospective cohort study

verfasst von: Martina Wolz-Beck, Christl Reisenauer, Giselle E. Kolenic, Sabine Hahn, Sara Y. Brucker, Markus Huebner

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To determine the efficacy of physiotherapy and behavior therapy and to find specific subgroups of women with overactive bladder syndrome that might gain increased benefit from this therapy.

Methods

Women with ≥10 micturitions per 24-h period were included. Six to nine therapy sessions were held within a 14-day interval. Efficacy end point was a reduction in micturitions and in episodes of nocturia. Secondary outcomes included ICIQ-OAB, ICIQ-OABqol and visual analog scales. Follow-up was 6 months. Levene test, Student’s t test, Pearson´s and Spearman’s correlations were utilized as well as the Friedman test and a multivariable-multilevel model.

Results

32 women were included. Mean age was 51 ± 15.9 (years ± standard deviation, sd). Mean body mass index (BMI) was 24.4 ± 4.8 (kg/m2 ± sd). There was a 22.9% reduction in the number of micturitions per 24 h (11.7 ± 1.6 vs. 9.0 ± 1.3 p < 0.001), a 21.3% reduction during the day (10.3 ± 1.4 vs. 8.1 ± 1.1 p < 0.001) and a 34.7% reduction in episodes of nocturia (1.5 ± 1.0 vs. 1.0 ± 0.8 p = 0.026). Both ICIQ-OAB (8.7 ± 2.3 vs. 5.8 ± 2.7 vs. 6.3 ± 3.3 p < 0.001) and ICIQ-OABqol (73.4 ± 25.9 vs. 47.5 ± 14.5 vs. 47.7 ± 18.6 p < 0.001) questionnaires as well as VAS (7.5 ± 1.4 vs. 4.1 ± 2.4 vs. 4.2 ± 2.7 p < 0.001) showed significant improvement persisting in the 6-month follow-up. In addition, in a multivariable model controlling for age, women who were overactive bladder syndrome therapy naïve responded significantly better than those who had already been under therapy (p < 0.001).

Conclusions

This study shows the efficacy of physiotherapy and behavior therapy in women with overactive bladder syndrome with a post-therapy effect especially for women with no prior treatment.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, Van Kerrebroeck P, Victor A, Wein A, Standardisation Sub-Committee of the International Continence S (2003) The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 61(1):37–49CrossRefPubMed Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, Van Kerrebroeck P, Victor A, Wein A, Standardisation Sub-Committee of the International Continence S (2003) The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 61(1):37–49CrossRefPubMed
2.
Zurück zum Zitat Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK, Schaer GN, International Urogynecological A, International Continence S (2010) An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn 29(1):4–20. doi:10.1002/nau.20798 PubMed Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK, Schaer GN, International Urogynecological A, International Continence S (2010) An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn 29(1):4–20. doi:10.​1002/​nau.​20798 PubMed
4.
Zurück zum Zitat Reynolds WS, McPheeters M, Blume J, Surawicz T, Worley K, Wang L, Hartmann K (2015) Comparative effectiveness of anticholinergic therapy for overactive bladder in women: a systematic review and meta-analysis. Obstet Gynecol 125(6):1423–1432. doi:10.1097/AOG.0000000000000851 CrossRefPubMed Reynolds WS, McPheeters M, Blume J, Surawicz T, Worley K, Wang L, Hartmann K (2015) Comparative effectiveness of anticholinergic therapy for overactive bladder in women: a systematic review and meta-analysis. Obstet Gynecol 125(6):1423–1432. doi:10.​1097/​AOG.​0000000000000851​ CrossRefPubMed
6.
Zurück zum Zitat Giarenis I, Cardozo L (2013) Management of refractory overactive bladder. Minerva Ginecol 65(1):41–52PubMed Giarenis I, Cardozo L (2013) Management of refractory overactive bladder. Minerva Ginecol 65(1):41–52PubMed
9.
Zurück zum Zitat Jackson S, Donovan J, Brookes S, Eckford S, Swithinbank L, Abrams P (1996) The bristol female lower urinary tract symptoms questionnaire: development and psychometric testing. Br J Urol 77(6):805–812CrossRefPubMed Jackson S, Donovan J, Brookes S, Eckford S, Swithinbank L, Abrams P (1996) The bristol female lower urinary tract symptoms questionnaire: development and psychometric testing. Br J Urol 77(6):805–812CrossRefPubMed
10.
Zurück zum Zitat Coyne K, Revicki D, Hunt T, Corey R, Stewart W, Bentkover J, Kurth H, Abrams P (2002) Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res 11(6):563–574CrossRefPubMed Coyne K, Revicki D, Hunt T, Corey R, Stewart W, Bentkover J, Kurth H, Abrams P (2002) Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res 11(6):563–574CrossRefPubMed
11.
Zurück zum Zitat Berghmans LC, Hendriks HJ, Bo K, Hay-Smith EJ, de Bie RA, van Waalwijk van Doorn ES (1998) Conservative treatment of stress urinary incontinence in women: a systematic review of randomized clinical trials. Br J Urol 82(2):181–191CrossRefPubMed Berghmans LC, Hendriks HJ, Bo K, Hay-Smith EJ, de Bie RA, van Waalwijk van Doorn ES (1998) Conservative treatment of stress urinary incontinence in women: a systematic review of randomized clinical trials. Br J Urol 82(2):181–191CrossRefPubMed
12.
Zurück zum Zitat Bo K, Finckenhagen HB (2001) Vaginal palpation of pelvic floor muscle strength: inter-test reproducibility and comparison between palpation and vaginal squeeze pressure. Acta Obstet Gynecol Scand 80(10):883–887CrossRefPubMed Bo K, Finckenhagen HB (2001) Vaginal palpation of pelvic floor muscle strength: inter-test reproducibility and comparison between palpation and vaginal squeeze pressure. Acta Obstet Gynecol Scand 80(10):883–887CrossRefPubMed
13.
Zurück zum Zitat de Oliveira Camargo F, Rodrigues AM, Arruda RM, Ferreira Sartori MG, Girao MJ, Castro RA (2009) Pelvic floor muscle training in female stress urinary incontinence: comparison between group training and individual treatment using PERFECT assessment scheme. Int Urogynecol J Pelvic Floor Dysfunct 20(12):1455–1462. doi:10.1007/s00192-009-0971-1 CrossRef de Oliveira Camargo F, Rodrigues AM, Arruda RM, Ferreira Sartori MG, Girao MJ, Castro RA (2009) Pelvic floor muscle training in female stress urinary incontinence: comparison between group training and individual treatment using PERFECT assessment scheme. Int Urogynecol J Pelvic Floor Dysfunct 20(12):1455–1462. doi:10.​1007/​s00192-009-0971-1 CrossRef
14.
Zurück zum Zitat Huebner M, Riegel K, Hinninghofen H, Wallwiener D, Tunn R, Reisenauer C (2010) Pelvic floor muscle training for stress urinary incontinence: a randomized, controlled trial comparing different conservative therapies. Physiother Res Int. doi:10.1002/pri.489 PubMed Huebner M, Riegel K, Hinninghofen H, Wallwiener D, Tunn R, Reisenauer C (2010) Pelvic floor muscle training for stress urinary incontinence: a randomized, controlled trial comparing different conservative therapies. Physiother Res Int. doi:10.​1002/​pri.​489 PubMed
15.
16.
Zurück zum Zitat Lauti M, Herbison P, Hay-Smith J, Ellis G, Wilson D (2008) Anticholinergic drugs, bladder retraining and their combination for urge urinary incontinence: a pilot randomised trial. Int Urogynecol J Pelvic Floor Dysfunct 19(11):1533–1543. doi:10.1007/s00192-008-0686-8 CrossRefPubMed Lauti M, Herbison P, Hay-Smith J, Ellis G, Wilson D (2008) Anticholinergic drugs, bladder retraining and their combination for urge urinary incontinence: a pilot randomised trial. Int Urogynecol J Pelvic Floor Dysfunct 19(11):1533–1543. doi:10.​1007/​s00192-008-0686-8 CrossRefPubMed
18.
Zurück zum Zitat Rentzhog L, Stanton SL, Cardozo L, Nelson E, Fall M, Abrams P (1998) Efficacy and safety of tolterodine in patients with detrusor instability: a dose-ranging study. Br J Urol 81(1):42–48CrossRefPubMed Rentzhog L, Stanton SL, Cardozo L, Nelson E, Fall M, Abrams P (1998) Efficacy and safety of tolterodine in patients with detrusor instability: a dose-ranging study. Br J Urol 81(1):42–48CrossRefPubMed
19.
Zurück zum Zitat Gormley EA, Lightner DJ, Faraday M, Vasavada SP, American Urological A, Society of Urodynamics FPM (2015) Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. J Urol 193(5):1572–1580. doi:10.1016/j.juro.2015.01.087 CrossRefPubMed Gormley EA, Lightner DJ, Faraday M, Vasavada SP, American Urological A, Society of Urodynamics FPM (2015) Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. J Urol 193(5):1572–1580. doi:10.​1016/​j.​juro.​2015.​01.​087 CrossRefPubMed
Metadaten
Titel
Physiotherapy and behavior therapy for the treatment of overactive bladder syndrome: a prospective cohort study
verfasst von
Martina Wolz-Beck
Christl Reisenauer
Giselle E. Kolenic
Sabine Hahn
Sara Y. Brucker
Markus Huebner
Publikationsdatum
30.03.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 5/2017
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-017-4357-1

Weitere Artikel der Ausgabe 5/2017

Archives of Gynecology and Obstetrics 5/2017 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.